NEW YORK (Reuters Health) – Inflammatory bowel disease (IBD) activity is an independent risk factor for the development of venous thromboembolic events (VTEs). That’s one of the findings…
NEW YORK (Reuters Health) – Among symptomatic children with chronic gastritis associated with Helicobacter pylori infection, the condition does not resolve spontaneously, and chronic inflammation tends to increase…
NEW YORK (Reuters Health) – A single dose of zoledronate prevents bone loss associated with glucocorticoid therapy given for acute exacerbation of Crohn’s disease, a German team reports…
NEW YORK (Reuters Health) – The incidence of esophageal adenocarcinoma in patients with nondysplastic Barrett’s esophagus is lower than previously reported, so less rigorous surveillance may be possible,…
NEW YORK (Reuters Health) – For patients with acute malignant obstruction of the left-sided colon, placement of colonic stents as a bridge to elective surgery offers no advantage…
NEW YORK (Reuters Health) – Eradication rates of Helicobacter pylori in children are higher with sequential therapy compared with standard triple therapy, a Polish team reports in the…
NEW YORK (Reuters Health) – Clinical practice guidelines on the management of hepatitis C infection, issued by the European Association for the Study of the Liver, underscore the…
NEW YORK (Reuters Health) – Erythromycin infusion fosters preparation of the upper gastrointestinal tract for endoscopy in patients with upper gastrointestinal bleeding without the need for nasogastric tube…
NEW YORK (Reuters Health) – Rifaximin improves driving simulator performance in patients with cirrhosis and minimal hepatic encephalopathy, researchers report in the February issue of Gastroenterology. “The study…
NEW YORK (Reuters Health) – Ribavirin added to pegylated interferon more than doubles the sustained viral response rate in children with chronic hepatitis C, a multicenter team reports…